About
Ablbio is a biotechnology company developing treatments for immune-oncology and neurodegenerative diseases using innovative bispecific antibody platforms and antibody-drug conjugates.
Explore Ablbio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.